Skip to main content
Menu
Main navigation
About Ipnet
About Ipnet sub-navigation
What is Ipnet ?
Statutes & bylaws
Membership application
Expert Clinical Center application
Ipnet Executive Board
General Assemblies
Ipnet Working Groups
Porphyria centres
Patient organizations
Corporate members
Honorary members
Patients
Patients sub-navigation
Introduction to porphyria
GPAC information statement
Acute porphyria
Drugs and acute hepatic porphyrias
Acute porphyria - diagnosis - FAQ
Porphyria Cutanea Tarda (PCT)
Erythropoietic Protoporphyrias (EPP & XLP)
Congenital erythropoietic porphyria (CEP)
Skin Protection in Cutaneous Porphyria
Patient organizations
Porphyria centres
Professionals
Professionals sub-navigation
The porphyrias
Laboratory diagnosis
Investigating the family
Treatment of the acute attack
Drugs and acute hepatic porphyrias
Acute porphyria: how to refer a patient
Porphyria Cutanea Tarda (PCT)
Erythropoietic protoporphyria (EPP & XLEPP)
Webinars
Porphyria centres
News
Research
Contact
2020 status of Givosiran, by Eliane Sardh
